Submit Deal

Announced

6 Sep 2022

Completed

6 Sep 2022

Virtue Diagnostics completed the acquisition of Labtest.

Synopsis

Virtue Diagnostics, an innovative IVD company focusing on Infectious Disease, Cancer, Maternal & Fetal Health, and Chronic Disease, completed the acquisition of Labtest, a laboratory equipment supplier. Financial terms were not disclosed. Labtest was chosen for our extensive know-how in the diagnostic, culture and training segment of its professionals.

Principals

target

Labtest Diagnóstica

bidder

Virtue Diagnostics

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (4)

vitor umbelino

Vice President at Lincoln International

Financial Advisor

target

Deals

n/a

Total Value

alexandre guimarães

CEO and President at LABTEST DIAGNÓSTICA

Manager

target

Deal

n/a

Total Value

luiz recchia

Managing Director at Lincoln International

Financial Advisor

target

Deals

n/a

Total Value

james sinclair

Managing Director at Lincoln International

Financial Advisor

target

Deals

n/a

Total Value

Bidder Team (1)

johnson zhang

CEO at VIRTUE DIAGNOSTICS

Manager

bidder

Deals

£ 74 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy